Mannitol and frusemide in the treatment of diuretic resistant oedema in nephrotic syndrome

Arch Dis Child. 1999 Feb;80(2):184-5. doi: 10.1136/adc.80.2.184.

Abstract

Three children (two girls aged 7 and 9 years, and one boy aged 4 years) with diuretic resistant oedema in steroid resistant nephrotic syndrome were treated with a combination of intravenous mannitol and frusemide. All three responded with loss of oedema of 10% to 30% of body weight over one week. There were no complications of hypertension or hypovolaemia. Mannitol-frusemide combination is a safe, inexpensive, and effective treatment for diuretic resistant oedema. Its use in other conditions and in developing countries (where the availability and purity of 20% albumin is limited) needs to be explored.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Child, Preschool
  • Diuretics / therapeutic use*
  • Diuretics, Osmotic / therapeutic use
  • Drug Therapy, Combination
  • Edema / drug therapy*
  • Edema / etiology
  • Female
  • Furosemide / therapeutic use*
  • Humans
  • Infusions, Intravenous
  • Male
  • Mannitol / therapeutic use*
  • Nephrotic Syndrome / complications*

Substances

  • Diuretics
  • Diuretics, Osmotic
  • Mannitol
  • Furosemide